Mutational analysis revealed that HR patients showed elevated tumor mutational burden, with driver mutations primarily enriched in genes involved in the regulation of genomic stability, including TP53, TTN, MUC16, CSMD3, and RYR2 (Supplementary Figure S4A). The gene discussed is TP53; the disease is neoplasm.